Portfolio
  • Havea-group-500x367.png
    Havea Group
    France / Private Equity

    Healthcare,Consumer

    Overview

    Havea Group is a leader in the Natural Consumer Healthcare industry in Europe. It manufactures, designs and distributes a wide range of products from functional and natural food supplements, to natural personal care products for babies and women through its world class plant in France. Havea is well positioned due to its multi-distribution channel strategy (pharma, mass market, D2C) and its 7 well-known strategic brands: Biolane, Vitavea, Nature Moi, Yves Ponroy, Aragan, Densmore and Dermovitamina. Havea has acquired 5 companies in the past 5 years to strengthen its presence in the pharmacy channel and internationally.

    Since inception, Havea has grown at a double digit rate each year organically and is well positioned to benefit from the consolidation taking place in this highly fragmented market and will continue to expand its international footprint in Europe, Asia and the Americas.

    Highlights

    • Strong future organic growth expected stemming from global mega trends in natural healthcare and well-being
    • Transitioned from a family-owned business with the nomination of a new management team including Nicolas Brodetsky, former CEO of Aragan
    • Supporting the management team to implement a complete digital strategy
    • Supporting M&A opportunities using our global network and strong experience which led to the acquisitions of Aragan within a few months of our ownership, Densmore in July 2018, Pasquali in Italy in April 2019, Laudavie in November 2020 and ixX pharma in Belgium in August 2021
    "3i is a great partner for Havea; its values and approach fit really well with our entrepreneurial mindset. They relentlessly look for growth while keeping the right balance between operational performance improvement and the strengthening and digitalisation of our core processes. In 4 years with 3i, we have doubled the size of the Group and made 5 acquisitions, including my own company” Nicolas Brodetsky, CEO, Havea

    Regulatory information 
    This transaction involved a recommendation of 3i Investments plc, advised by 3i France.

Back to top